Hoth Therapeutics, Inc. (HOTH) a New York-based biopharmaceutical company, Friday announced that it has been notified by Nasdaq's Listing Qualifications Department that it has regained compliance with the minimum bid price requirement outlined in Listing Rule 5550(a)(2).
The notification comes as the company's common stock maintained a closing bid price of $1.00 or higher for 10 consecutive business days, from January 7 to January 22, 2025.
Currently, HOTH is trading at $1.518 or 3.2720 percent higher on the Nasdaq Capital Market.
For comments and feedback: editorial@rttnews.com